What Should You know About Northrop Grumman (NOC) Before Investing?

Northrop Grumman logged a 0.6% change during today's afternoon session, and is now trading at a price of $435.62 per share. On average, analysts give it a target price of $504.06.

Northrop Grumman Corporation operates as an aerospace and defense company worldwide. The large-cap company is based in the United States. Northrop Grumman currently returns an annual dividend yield of 1.6%.

Make Sure to Consider the Following Before Buying Northrop Grumman:

  • Northrop Grumman has moved -8.0% over the last year.

  • NOC has a forward P/E ratio of 17.7 based on its EPS guidance of 24.66.

  • Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of 10.7%.

  • The company has a price to earnings growth (PEG) ratio of 10.11.

  • Its Price to Book (P/B) ratio is 4.26

Northrop Grumman Has a Deteriorating Pattern of Cash Flows

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023-01-26 2,901,000 -1,280,000 4,181,000 -14.64
2022-01-27 3,567,000 -1,331,000 4,898,000 -11.27
2021-01-28 4,305,000 -1,215,000 5,520,000 -0.74
2020-01-30 4,297,000 -1,264,000 5,561,000 9.55
2019-01-31 3,827,000 -1,249,000 5,076,000 43.35
2018-01-29 2,613,000 -928,000 3,541,000

Northrop Grumman's free cash flows may average out to $4.8 Billion over the last 6 years, but its persistently negative year-on-year growth could be a red flag. Indeed, its free cash flow CAGR is 0.0% and its coefficient of variability is 18146483747.0%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.